Total Payments
$3,749
2024 Payments
$777.09
Companies
36
Transactions
168
Medicare Patients
5,459
Medicare Billing
$337,793
Payment Breakdown by Category
Food & Beverage$3,635 (97.0%)
Other$113.64 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,635 | 167 | 97.0% |
| Grant | $113.64 | 1 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $590.69 | 36 | $0 (2023) |
| Boston Scientific Corporation | $399.83 | 10 | $0 (2024) |
| ABBVIE INC. | $387.96 | 13 | $0 (2024) |
| PFIZER INC. | $309.70 | 19 | $0 (2024) |
| Janssen Biotech, Inc. | $211.41 | 7 | $0 (2024) |
| COLOPLAST CORP | $186.25 | 6 | $0 (2024) |
| Axonics, Inc. | $165.43 | 3 | $0 (2024) |
| Blue Earth Diagnostics Limited | $118.46 | 4 | $0 (2024) |
| ACCORD HEALTHCARE, INC. | $116.95 | 5 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $110.54 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.09 | 30 | Janssen Biotech, Inc. ($130.93) |
| 2023 | $710.09 | 31 | ABBVIE INC. ($210.32) |
| 2022 | $476.10 | 17 | Coloplast Corp ($121.80) |
| 2021 | $340.51 | 16 | Astellas Pharma US Inc ($126.50) |
| 2020 | $262.63 | 15 | Astellas Pharma US Inc ($71.29) |
| 2019 | $415.95 | 20 | Boston Scientific Corporation ($126.73) |
| 2018 | $409.88 | 16 | BOSTON SCIENTIFIC CORPORATION ($126.96) |
| 2017 | $356.55 | 23 | Astellas Pharma US Inc ($183.18) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: UROLOGY | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: UROLOGY | ||||||
| 09/23/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Diagnostic Imaging | ||||||
| 09/18/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: rezum_URO | ||||||
| 09/17/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Oncology | ||||||
| 09/06/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Prostate cancer | ||||||
| 08/12/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: UROLOGY | ||||||
| 08/05/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: rezum_URO | ||||||
| 06/17/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: UROLOGY | ||||||
| 06/11/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Urology Gynecology | ||||||
| 06/05/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $60.33 | General |
| Category: Urology | ||||||
| 05/30/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Urology Gynecology | ||||||
| 05/17/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: UROLOGY | ||||||
| 04/26/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $116.73 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: UROLOGY | ||||||
| 04/15/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Diagnostic Imaging | ||||||
| 04/12/2024 | COLOPLAST CORP | Coloplast TFL Drive (Device) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Endourology | ||||||
| 03/29/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,627 | 2,100 | $328,398 | $93,031 |
| 2022 | 28 | 1,392 | 1,814 | $304,151 | $88,729 |
| 2021 | 19 | 1,221 | 1,549 | $223,213 | $77,429 |
| 2020 | 29 | 1,219 | 1,667 | $219,708 | $78,605 |
Total Patients
5,459
Total Services
7,130
Medicare Billing
$337,793
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 383 | $107,535 | $33,446 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 147 | 147 | $52,992 | $16,862 | 31.8% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 22 | 69 | $21,692 | $4,747 | 21.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 18 | 23 | $12,027 | $4,107 | 34.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 23 | 28 | $31,170 | $3,332 | 10.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 22 | $8,603 | $2,984 | 34.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 48 | $7,854 | $2,932 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 40 | $8,402 | $2,619 | 31.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 200 | 243 | $5,895 | $1,865 | 31.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $5,209 | $1,828 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $5,262 | $1,718 | 32.7% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 22 | 46 | $16,352 | $1,582 | 9.7% |
| 87529 | Detection test by nucleic acid for herpes simplex virus, amplified probe technique | Office | 2023 | 22 | 46 | $9,053 | $1,582 | 17.5% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 22 | 46 | $5,404 | $1,582 | 29.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 70 | 83 | $3,393 | $1,470 | 43.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,875 | $1,072 | 27.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 306 | 423 | $2,216 | $925.18 | 41.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 39 | 49 | $2,502 | $858.69 | 34.3% |
| 87496 | Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique | Office | 2023 | 22 | 23 | $1,790 | $790.97 | 44.2% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 22 | 23 | $1,790 | $790.97 | 44.2% |
| 87532 | Detection test by nucleic acid for herpes virus-6, amplified probe technique | Office | 2023 | 22 | 23 | $1,790 | $790.97 | 44.2% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 22 | 23 | $1,790 | $790.97 | 44.2% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 22 | 23 | $1,790 | $790.97 | 44.2% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 22 | 23 | $1,790 | $790.97 | 44.2% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 31 | 36 | $1,472 | $636.29 | 43.2% |
About Dr. Christopher Pace, MD
Dr. Christopher Pace, MD is a Urology healthcare provider based in Grapevine, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912993080.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Pace, MD has received a total of $3,749 in payments from pharmaceutical and medical device companies, with $777.09 received in 2024. These payments were reported across 168 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,635).
As a Medicare-enrolled provider, Pace has provided services to 5,459 Medicare beneficiaries, totaling 7,130 services with total Medicare billing of $337,793. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Grapevine, TX
- Active Since 09/23/2005
- Last Updated 07/17/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1912993080
Products in Payments
- XTANDI (Drug) $479.12
- MYRBETRIQ (Drug) $238.70
- BOTOX (Biological) $201.99
- ERLEADA (Drug) $186.54
- Myrbetriq (Drug) $161.60
- GENERAL BPH (Device) $126.96
- GENERAL BPH (Device) $126.73
- LUPRON DEPOT (Drug) $125.75
- CAMCEVI (Drug) $116.95
- JELMYTO (Drug) $106.88
- XIAFLEX (Biological) $104.34
- Isiris aStent Removal Device (Device) $104.10
- Erleada (Drug) $94.82
- Bulkamid (Device) $83.77
- iTIND System (Device) $83.67
- GEMTESA (Drug) $83.16
- AVEED (Biological) $82.93
- Axonics (Device) $81.66
- Axumin (Drug) $75.48
- PROVENGE (Drug) $67.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Grapevine
Bryan Bruner, Md, MD
Urology — Payments: $9,088
Urology $9,088
Dr. Scott Davidson, M.d, M.D
Urology — Payments: $5,921
Urology $5,921
Dr. Steven Ash, M.d, M.D
Urology — Payments: $5,076
Urology $5,076
Dr. Nathan Graves, M.d, M.D
Urology — Payments: $3,591
Urology $3,591
Patrick Frey, Md, MD
Urology — Payments: $2,989
Urology $2,989